 Vident Investment Advisory LLC bought a new position in Cue Biopharma Inc NASDAQ:CUE during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 52,900 shares of the companys stock, valued at approximately 1,297,000. Vident Investment Advisory LLC owned about 0.19 of Cue Biopharma as of its most ... 